FIS

FCPM III Services Portfolio holdings

AUM $369M
1-Year Est. Return 29.21%
This Quarter Est. Return
1 Year Est. Return
-29.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$414M
AUM Growth
-$179M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
8
New
Increased
Reduced
Closed

Top Buys

1
+$6.92M
2
+$5.07M

Top Sells

1
+$2.75M
2
+$594K

Sector Composition

1 Healthcare 99.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$4.1B
$224M 54.11%
10,935,310
+338,129
DYN icon
2
Dyne Therapeutics
DYN
$2.33B
$57.1M 13.81%
5,462,846
ENGN icon
3
enGene Holdings
ENGN
$479M
$43.2M 10.43%
9,632,561
REPL icon
4
Replimune Group
REPL
$351M
$38.1M 9.21%
3,909,696
-60,972
BCYC
5
Bicycle Therapeutics
BCYC
$566M
$29.3M 7.08%
3,452,330
ATXS icon
6
Astria Therapeutics
ATXS
$676M
$20.4M 4.93%
3,822,537
+950,000
ENGNW icon
7
enGene Holdings Warrants
ENGNW
$25.8M
$1.73M 0.42%
2,878,148
ACHL
8
DELISTED
Achilles Therapeutics
ACHL
– –
-2,390,050